Skip to main content
Livermore
Livermore
ZHEN

Wedbush Securities Inc

SEC CIK
0001142495
Latest filing
Jul 28, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Wedbush Securities Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of REGN by Wedbush Securities Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−634−100.0%Sold outHolders
Q1 2026634$490.0K<0.1%+1+0.2%AddedHolders
Q4 2025633$489.0K<0.1%−215−25.4%ReducedHolders
Q3 2025848$477.0K<0.1%−46−5.1%ReducedHolders
Q2 2025894$469.0K<0.1%+23+2.6%AddedHolders
Q1 2025871$552.0K<0.1%+28+3.3%AddedHolders
Q4 2024843$600.0K<0.1%+54+6.8%AddedHolders
Q3 2024789$829.0K<0.1%+121+18.1%AddedHolders
Q2 2024668$702.0K<0.1%−28−4.0%ReducedHolders
Q1 2024696$670.0K<0.1%+102+17.2%AddedHolders
Q4 2023594$522.0K<0.1%−7−1.2%ReducedHolders
Q3 2023601$495.0K<0.1%−55−8.4%ReducedHolders
Q2 2023656$471.0K<0.1%+38+6.1%AddedHolders
Q1 2023618$508.0K<0.1%+67+12.2%AddedHolders
Q4 2022551$398.0K<0.1%−73−11.7%ReducedHolders
Q3 2022624$430.0K<0.1%−117−15.8%ReducedHolders
Q2 2022741$438.0K<0.1%−93−11.2%ReducedHolders
Q1 2022834$582.0K<0.1%−36−4.1%ReducedHolders
Q4 2021870$549.0K<0.1%+238+37.7%AddedHolders
Q3 2021632$382.0K<0.1%−9−1.4%ReducedHolders
Q2 2021641$358.0K<0.1%−160−20.0%ReducedHolders
Q1 2021801$379.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.